PubMed Health⌕ Search

Biomedical subjects

Alexander Samel

Publications and source records attributed to Alexander Samel.

4 recordsLinked to original sources
PubMed2006

Aircraft noise effects on sleep: application of the results of a large polysomnographic field study.

The Institute of Aerospace Medicine at the German Aerospace Center (DLR) investigated the influence of nocturnal aircraft noise on sleep in polysomnographic laboratory and field studies between 1999 and 2004. The results of the field studies were used by the Regional Council of Leipzig (Germany) for the establishment of a noise protection plan in the official approval process for the expansion of Leipzig/Halle airport. Methods and results of the DLR field study are described in detail. Special attention is given to the dose-response relationship between the maximum sound pressure level of an aircraft noise event and the probability to wake up, which was used to establish noise protection zones directly related to the effects of noise on sleep. These protection zones differ qualitatively and quantitatively from zones that are solely based on acoustical criteria. The noise protection plan for Leipzig/Halle airport is presented and substantiated: (1) on average, there should be less than one additional awakening induced by aircraft noise, (2) awakenings recalled in the morning should be avoided as much as possible, and (3) aircraft noise should interfere as little as possible with the process of falling asleep again. Issues concerned with the representativeness of the study sample are discussed.

Acoustics↗
PubMed2004

Sleep deficit and stress hormones in helicopter pilots on 7-day duty for emergency medical services.

INTRODUCTION: Helicopter-based emergency medical services in Germany operate from sunrise to sunset, requiring up to 15.5 h of continuous duty during the summer months for pilots, who work for seven consecutive days. Because of concerns regarding the safety of this procedure with respect to pilot fatigue and stress, the German Ministry of Transport asked our laboratory to investigate the risks involved. METHODS: There were 13 pilots (mean age 38 yr) who were studied in the summer months for 2 d before, 7 d during, and 2 d after their duty cycle. Measured variables included sleep duration and quality, subjective fatigue, and heart rate, as well as 24-h excretion levels of stress hormones. RESULTS: During actual helicopter operations, maximum heart rates did not exceed 120 bpm. Over the 7-d duty period, mean sleep duration decreased from 7.8 h to 6 h or less, resulting in a cumulative sleep loss of about 15 h. Mean levels of excreted adrenalin, noradrenalin, and cortisol increased significantly by 50 to 80%; cortisol and noradrenalin excretion also remained elevated for the two post-duty days. CONCLUSIONS: Although the actual flights did not cause critical physiological responses, the acute and accumulated sleep deficit led to incomplete recuperation between duty hours and induced elevated stress indicators. It was, therefore, recommended that the duty cycle be amended as follows: 1.) enforce a 10-h rest period and at least an 8-h sleep opportunity per day; 2.) modify the duty period to allow no more than 3 consecutive rest periods of reduced sleep opportunities (8.5 h); and 3.) follow duty with several days that offer unrestricted sleep opportunities.

Adult↗
PubMed2002

Chronobiotic effects of the melatonin agonist LY 156735 following a simulated 9h time shift: results of a placebo-controlled trial.

INTRODUCTION: The melatonin agonist LY 156735 (LY) is a new investigational drug under development to treat circadian rhythm disorders. The present study assessed the efficacy of LY to alleviate the symptoms of shift lag and to enhance readaptation of desynchronized circadian rhythms to a new time zone. SUBJECTS AND METHODS: Eight healthy male volunteers of age 25-35 yr participated in three identical trials of 13d duration in a temporal isolation unit separated by washout intervals. A high dose (HD) of 5 mg and a low dose (LD) of 0.5 mg of LY and placebo (PL) were administered double-blinded in a three-period cross-over design. Each trial consisted of an adaptation period, a pre-shift period for baseline measurements, a simulated 9h phase-advance shift, and a post-shift period for follow-up. The time shift was performed at 23:00h of day 6 by advancing the laboratory time to 08:00h of day 7. Double-blind study medication was administered at 14:30h on day 6, and at 22:30h on days 7-10. Subjective ratings of jet lag, alertness, tenseness, and daytime fatigue were assessed using visual analog scales (VAS) and standardized questionnaires. The objective markers of readaptation included core body temperature, wrist actigraphy, cortisol and electrolyte excretion, and a battery of computerized performance tests. RESULTS: HD but not LD enhanced the readaptation speed of all physiological rhythms investigated, as demonstrated by a significantly faster movement of acrophases towards the post-shift target time. HD (p = 0.05) significantly blunted the post-shift deterioration of performance in those tests that were sensitive to shift lag. Parameters of subjective well-being were not significantly affected by either dose. CONCLUSION: This pilot study demonstrates the chronobiotic efficacy of LY when taken at a dose of 5 mg/d.

Adaptation, Physiological↗